Researchers at Beth Israel Deaconess Medical Center in Boston report that the DASH diet does not significantly raise potassium levels or alter kidney function in people taking high blood pressure medication.
The U.S. Department of Justice issued a new directive last week to combat white-collar fraud by explicitly including pharmaceutical manufacturers under federal law.
Writer Cathal J Ferris has created a new production called The Corner Man that examines the mental health challenges facing retired boxers.
Biotech company Forbion announced it has raised $2.6 billion, marking its largest fundraising event ever.
A Dutch court ruled that Merck infringed a patent on its subcutaneous Keytruda formulation and ordered the company to halt production and sales in several European nations.
Lawmakers from both major parties are targeting pharmacy benefit managers as a shared healthcare issue while states like Tennessee and Arkansas move to regulate them.
The World Health Organization is requesting more information regarding the death of a female employee at a Russian plague research facility.
A new study published Wednesday in the New England Journal of Medicine reports that optogenetics restored partial vision to patients with retinitis pigmentosa.
UT Southwestern Medical Center scientists report that disabling the p53 tumor suppressor gene triggers a chain reaction affecting cell metabolism and genetic stability.
The Trump administration announced a proposed $70,000 fee on Wednesday for the Optional Practical Training work authorization program.
